As of 2025-11-13, the Relative Valuation of Nanobiotix SA (NANO.PA) is (2.15) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 18.52 EUR, the upside of Nanobiotix SA based on Relative Valuation is -111.6%.
The range of the Relative Valuation is (1.72) - (4.03) EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 1.6x - 4.2x | 2.0x |
| Forward P/E multiples | 1.6x - 3.7x | 2.0x |
| Fair Price | (1.72) - (4.03) | (2.15) |
| Upside | -109.3% - -121.8% | -111.6% |
| Date | P/E |
| 2025-11-05 | -16.23 |
| 2025-11-04 | -16.11 |
| 2025-11-03 | -14.63 |
| 2025-10-31 | -16.62 |
| 2025-10-30 | -15.19 |
| 2025-10-29 | -14.41 |
| 2025-10-28 | -14.37 |
| 2025-10-27 | -12.40 |
| 2025-10-24 | -14.96 |
| 2025-10-23 | -16.47 |
| 2025-10-22 | -17.84 |
| 2025-10-21 | -18.80 |
| 2025-10-20 | -20.33 |
| 2025-10-17 | -20.70 |
| 2025-10-16 | -22.05 |
| 2025-10-15 | -21.95 |
| 2025-10-14 | -22.28 |
| 2025-10-13 | -22.70 |
| 2025-10-10 | -20.79 |
| 2025-10-09 | -22.19 |
| 2025-10-08 | -20.61 |
| 2025-10-07 | -16.91 |
| 2025-10-06 | -17.19 |
| 2025-10-03 | -15.78 |
| 2025-10-02 | -15.69 |
| 2025-10-01 | -15.06 |
| 2025-09-30 | -15.48 |
| 2025-09-29 | -13.09 |
| 2025-09-26 | -12.22 |
| 2025-09-25 | -11.86 |
| 2025-09-24 | -11.73 |
| 2025-09-23 | -10.68 |
| 2025-09-22 | -10.34 |
| 2025-09-19 | -9.07 |
| 2025-09-18 | -10.04 |
| 2025-09-17 | -8.41 |
| 2025-09-16 | -7.88 |
| 2025-09-15 | -7.38 |
| 2025-09-12 | -7.77 |
| 2025-09-11 | -7.90 |
| 2025-09-10 | -7.62 |
| 2025-09-09 | -7.31 |
| 2025-09-08 | -6.96 |
| 2025-09-05 | -6.68 |
| 2025-09-04 | -6.78 |
| 2025-09-03 | -6.84 |
| 2025-09-02 | -6.71 |
| 2025-09-01 | -7.05 |
| 2025-08-29 | -7.29 |
| 2025-08-28 | -7.24 |